The US Food and Drug Administration (FDA) has approved Cobenfy, a up-to-date breakthrough drug for schizophrenia that promises to revolutionize treatment with a novel mechanism, the first of its kind in decades. Schizophrenia is a solemn and disabling mental illness that affects the way a person thinks, feels and behaves. Approximately 1% of Americans suffer […]
Glioblastoma multiforme is an extremely aggressive brain tumor that is currently incurable. Oncologists can extend the life expectancy of patients with surgery, radiotherapy, chemotherapy, or surgical interventions. However, half of patients die within twelve months of diagnosis. Drugs that are effective against brain tumors are demanding to find because many cancer drugs often can’t cross […]
For those struggling with scorching flashes and night sweats, here’s a promising development in menopause treatment. In a phase 3 clinical trial, researchers found that a recent non-hormonal drug, Elinzanetant, could reduce the frequency and severity of vasomotor symptoms in menopausal women. The often nightmarish discomfort that women go through during menopause includes symptoms such […]
A breakthrough in biomedical research promises recent insights into developing immunotherapy and disease modeling. Researchers at the University of Texas Health Science Center at San Antonio have created a humanized mouse model with a human immune system and a gut microbiome similar to that of humans that is capable of generating specific antibody responses. The […]
